Document is current
Any future updates will be listed below
-
Authors
Sinclair, David R.
Maharani, Asri
Kingston, Andrew
O’Neill, Terence W.
Matthews, Fiona E.
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (PR-PRU-1217-2150, PR-PRU-1217-2150, PR-PRU-1217-2150, PR-PRU-1217-2150, PR-PRU-1217-2150)
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 29 April 2025
First Online: 9 May 2025
Declarations
:
: ELSA Wave 9 received ethical approval from the South Central—Berkshire Research Ethics Committee on 10th May 2018 (17/SC/0588). ELSA Wave 8 received ethical approval from the South Central—Berkshire Research Ethics Committee on 23rd September 2015 (15/SC/0526). ELSA Wave 7 received ethical approval from the NRES Committee South Central—Berkshire on 28th November 2013 (13/SC/0532). ELSA Wave 6 received ethical approval from the NRES Committee South Central—Berkshire on 28th November 2012 (11/SC/0374). ELSA Wave 5 received ethical approval from the Berkshire Research Ethics Committee on 21st December 2009 (09/H0505/124). ELSA Wave 4 received ethical approval from the National Hospital for Neurology and Neurosurgery & Institute of Neurology Joint Research Ethics Committee on 12th October 2007 (07/H0716/48). ELSA Wave 3 received ethical approval from the London Multi-Centre Research Ethics Committee on 27th October 2005 (05/MRE02/63). ELSA Wave 2 received ethical approval from the London Multi-Centre Research Ethics Committee on 12th August 2004 (MREC/04/2/006). ELSA Wave 1 received ethical approval from the London Multi-Centre Research Ethics Committee on 7th February 2002 (MREC/01/2/91). ELSA participants give written informed consent at recruitment. At subsequent waves, participant consent is reaffirmed in writing, except for telephone interviews where verbal consent is reaffirmed.
: N/A.
: The authors declare no competing interests.
